Davido and Fehr received new R21 grant of $411,500 from the NIH National Institute of Allergy and Infectious Diseases
David Davido, Tony Fehr (Molecular Bioscience), received $411,500 from the NIH National Institute of Allergy and Infectious Diseases for a two-year R21 grant title, "Determining the role of PARP14 in restricting HSV-1 replication".